Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Clinical trial NCT00088179 · COMPLETED

Trial details

NCT number: NCT00088179
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2004-07-01
Primary completion: 2005-10-01
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.